no positive for any of the kids that couldn't get access to Rem-L for GvHD, some residual benefit to MSB as it's another hurdle that a competitor would need to jump to get in the market especially if any of the new CMC or potency assay process is patentable.
no positive for any of the kids that couldn't get access to...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.06 |
Change
-0.003(0.23%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.09 | $1.06 | $2.207M | 2.061M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 128222 | $1.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 35197 | 13 |
View Market Depth
| Last trade - 12.03pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.07 |
Change
-0.003 ( 0.31 %) |
||||
| Open | High | Low | Volume | ||
| $1.09 | $1.09 | $1.06 | 416922 | ||
| Last updated 12.20pm 15/05/2024 ? | |||||
| MSB (ASX) Chart |